Cellular Goods Plc (CLAI) AI Stock Analysis

• Market Cap: £5.27M
• Dividend Yield: N/A
• Average Volume (3M): 45.94M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.84
• Revenue Growth: -73.31%
• EPS Growth: 47.54%
• Country: UK
• Employees: 1
• Sector: Consumer Defensive
• Sector Strength: 61
• Industry: Household & Personal Products
• EPS (TTM): 0.00
• Shares Outstanding: 752,423,600
• 10 Day Avg. Volume: 133,609,935
• 30 Day Avg. Volume: 45,941,959
• PEG Ratio: -0.02
• Price to Book (P/B): 2.17
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.74
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: ―

The overall score reflects significant financial challenges, with ongoing profitability and cash flow issues as the primary concern. Technical indicators show some positive momentum, but high volatility and poor valuation metrics diminish the stock's appeal. The recent corporate events offer a potential upside if new leadership can successfully navigate strategic improvements.

Cellular Goods Plc Business Overview & Revenue Model

Company Description

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.

How the Company Makes Money

Cellular Goods Plc generates revenue primarily through the sale of its skincare and wellness products, which are distributed both online and through retail partnerships. The company focuses on leveraging advancements in biosynthetic cannabinoid production to create high-quality, sustainable consumer goods. Key revenue streams include direct-to-consumer sales via its e-commerce platform and wholesale partnerships with retailers. Cellular Goods also invests in research and development to expand its product line and improve its formulations, which can enhance its market position and drive future sales growth.

Cellular Goods Plc Financial Statement Overview

Summary

Cellular Goods Plc is facing significant financial challenges, particularly in achieving profitability and positive cash flow. While revenue growth is a positive sign, the company struggles with operational efficiency, as shown by negative profit margins and cash flows. The balance sheet remains relatively sound due to a lack of debt, but declining equity and ongoing losses pose risks to financial stability. Overall, the company needs to focus on cost control and operational improvements to achieve sustainability.

Income Statement

The company has shown significant revenue growth from 2023 to 2024, with revenue increasing from 67,236 to 17,942. However, profitability remains a major concern, as reflected by negative EBIT and net profit margins. The negative margins indicate ongoing issues in controlling operational costs and achieving profitability.

Balance Sheet

The company has a solid equity base with no debt, resulting in a debt-to-equity ratio of zero. However, the return on equity is negative due to consistent net losses, indicating inefficiencies in generating returns for shareholders. The equity ratio shows a healthy proportion of equity in the asset structure, but the declining equity over the years is a concern.

Cash Flow

The company is experiencing negative free cash flow, indicating more cash outflow than inflow from operations and investments. The operating cash flow to net income ratio is negative due to persistent operating losses, suggesting challenges in converting revenue to cash. The free cash flow to net income ratio also highlights the inability to generate free cash flow relative to net income.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
54.16K	17.94K	67.24K	28.90K	0.00	0.00
	Gross Profit
33.81K	10.26K	41.44K	793.71K	0.00	0.00
	EBIT
-2.14M	-1.85M	-3.33M	-5.99M	-3.33M	-329.95K
	EBITDA
-742.12K	-1.19M	-3.28M	0.00	0.00	0.00
	Net Income Common Stockholders
-2.11M	-1.83M	-3.31M	-5.99M	-3.33M	-329.89K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.93M	213.63K	1.77M	4.38M	10.32M	9.22K
	Total Assets
3.60M	654.98K	2.45M	5.13M	10.75M	99.05K
	Total Debt
0.00	0.00	0.00	0.00	0.00	0.00
	Net Debt
-2.93M	-213.63K	-1.77M	-4.38M	-10.32M	-9.22K
	Total Liabilities
392.89K	140.43K	185.80K	279.13K	200.25K	182.29K
	Stockholders Equity
3.20M	514.55K	2.26M	4.85M	10.55M	-83.24K
Cash Flow		Free Cash Flow
-1.92M	-1.50M	-2.63M	-5.97M	-2.75M	-186.78K
	Operating Cash Flow
-1.92M	-1.10M	-2.63M	-5.97M	-2.75M	-186.78K
	Investing Cash Flow
-849.00	-458.27K	22.81K	1.30K	522.00	63.00
	Financing Cash Flow
0.00	0.00	0.00	25.00K	13.06M	191.28K

Cellular Goods Plc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.70
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CLAI, the sentiment is Positive. The current price of 0.7 is above the 20-day moving average (MA) of 0.46, above the 50-day MA of 0.31, and above the 200-day MA of 0.17, indicating a bullish trend. The MACD of 0.13 indicates Negative momentum. The RSI at 60.43 is Neutral, neither overbought nor oversold. The STOCH value of 57.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CLAI.

Cellular Goods Plc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CBOX	79 Outperform	£83.60M	15.35	27.25%	5.00%	7.46%	9.36%
CRDA	68 Neutral	£4.23B	26.67	6.84%	3.63%	-3.92%	-7.30%
Sector *	65 Neutral	$8.88B	15.05	4.75%	203.76%	3.54%	-2.50%
PZC	60 Neutral	£358.66M	―	-2.48%	4.21%	-16.16%	80.50%
REVB	59 Neutral	£23.07M	―		―	-14.61%	97.35%
KETL	57 Neutral	£102.40M	22.36	4.44%	9.43%	-1.95%	-110.12%
CLAI	39 Underperform	£5.27M	―	-130.38%	―	-73.31%	47.54%

Cellular Goods Plc Corporate Events

Cel AI PLC Announces Board Changes and Warrant Issuance

Cel AI PLC has announced significant changes in its board composition with Michael Edwards resigning as Executive Chairman and Olivia Edwards stepping in as the new Executive Chairperson. Olivia Edwards brings a wealth of experience in strategic financing and public listing processes across various industries. Additionally, Cel AI has issued 23,000,000 warrants to directors and service providers to subscribe for new ordinary shares, which could potentially enhance stakeholder value and align interests with company growth.